Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/11168
Full metadata record
DC FieldValueLanguage
dc.contributor.authorChua, Kyra Y Len
dc.contributor.authorLaurent, Fredericen
dc.contributor.authorCoombs, Geoffrey Wen
dc.contributor.authorGrayson, M Lindsayen
dc.contributor.authorHowden, Benjamin Pen
dc.date.accessioned2015-05-16T00:45:21Z
dc.date.available2015-05-16T00:45:21Z
dc.date.issued2011-01-01en
dc.identifier.citationClinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America; 52(1): 99-114en
dc.identifier.govdoc21148528en
dc.identifier.otherPUBMEDen
dc.identifier.urihttp://ahro.austin.org.au/austinjspui/handle/1/11168en
dc.description.abstractThere is significant diversity in methicillin-resistant Staphylococcus aureus (MRSA) clones arising in the community worldwide, with considerable geographical differences in typical antimicrobial resistance profiles. Many community clones of MRSA have a non-multidrug resistant antimicrobial profile, providing increased options for empirical and directed therapy of infections caused by these strains. However, the recent description of increasing non-β lactam resistance in community clones of MRSA, especially USA300, provides a timely warning for clinicians making decisions about therapy for patients potentially infected with these strains. Continued monitoring of global epidemiology and emerging drug resistance data is critical for the effective management of these infections.en
dc.language.isoenen
dc.subject.otherAnti-Bacterial Agents.pharmacologyen
dc.subject.otherCommunity-Acquired Infections.epidemiology.microbiologyen
dc.subject.otherDrug Resistance, Bacterialen
dc.subject.otherHumansen
dc.subject.otherMethicillin-Resistant Staphylococcus aureus.drug effects.isolation & purificationen
dc.subject.otherMicrobial Sensitivity Testsen
dc.subject.otherPandemicsen
dc.subject.otherStaphylococcal Infections.epidemiology.microbiologyen
dc.titleAntimicrobial resistance: Not community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA)! A clinician's guide to community MRSA - its evolving antimicrobial resistance and implications for therapy.en
dc.typeJournal Articleen
dc.identifier.journaltitleClinical infectious diseases : an official publication of the Infectious Diseases Society of Americaen
dc.identifier.affiliationInfectious Diseases, Austin Health, Heidelberg, Victoria, Australiaen
dc.identifier.doi10.1093/cid/ciq067en
dc.description.pages99-114en
dc.relation.urlhttp://www.ncbi.nlm.nih.gov/pubmed/21148528en
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.